Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
8,019.40
-3.30
(-0.04%)
AUD/USD
0.6604
+0.0000
(+0.00%)
ASX 200
7,750.00
+1.00
(+0.01%)
OIL
78.44
+0.18
(+0.23%)
GOLD
2,355.20
-19.80
(-0.83%)
Bitcoin AUD
94,644.12
+2,433.91
(+2.64%)
Regen BioPharma, Inc. (RGBP)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.6750
+0.1150
(+20.54%)
At close: 03:05PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Cash flow
All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-839.786
1,024
2,227
-6,765
2,732
Stock-based compensation
-
348.372
0
0.001
-
Change in working capital
-50.009
-1,929
-3,137
6,300
-4,009
Accounts receivable
39.399
254.272
-41.082
-109.999
-34.1
Accounts payable
-4.249
0.875
-62.705
-18.988
18.487
Other working capital
-482.07
-173.917
-606.921
-1,131
18.645
Other non-cash items
258.42
249.715
116.568
-1,823
613.122
Net cash provided by operating activities
-482.07
-173.917
-606.921
-1,131
18.645
Cash flows from investing activities
Sales/maturities of investments
-
-
25
495
0
Net cash used for investing activities
-
-
25
495
0
Cash flows from financing activities
Debt repayment
-
-
-94.535
-
-26.5
Common stock issued
-
-
-
-
0
Net cash used provided by (used for) financing activities
472.484
243.75
-94.036
1,363
-26.5
Net change in cash
-10.039
69.833
-675.957
727.162
-7.855
Cash at beginning of period
87.7
51.204
727.162
0
7.855
Cash at end of period
78.114
121.037
51.204
727.162
0
Free cash flow
Operating cash flow
-482.07
-173.917
-606.921
-1,131
18.645
Free cash flow
-482.07
-173.917
-606.921
-1,131
18.645
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.